Catalyst Funds Management’s Summit Therapeutics SMMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$475K	Buy	+22,300	New	+$475K	0.13%	206
2024 Q3	–	Sell	-6,900	Closed	-$53.8K	–	1581
2024 Q2	$53.8K	Buy	+6,900	New	+$53.8K	0.01%	401